Scholars Central

ArticlePublished 16 Jan 2023

Major Manifestations of COVID-19 Associated Mucormycosis

Authors: Julie Ann Thomas, Vinoth S, Komal Muneshwar, Ashok Mehendale

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: The Coronavirus outbreak has significantly destroyed mankind claiming countless lives all around the world. The clinical stretch of Coronavirus may vary in terms of severity extending from mild or subclinical condition to intensively severe pneumonia further sophisticated by fungal coinfections. Following the emergence of the pandemic, the emergence of innumerable secondary opportunistic fungal infections has created scope for another life threatening disease. Among these, mucormycosis has recently become a cause of anxiety due to its swift spread in patients with COVID-19 infection, during or after their treatment. The black fungus is a lethal obstacle reported commonly in COVID-19 positive patients worldwide. Many reports show that neutropenic patients are more vulnerable to these fungal infections due to immense utilisation of chemotherapy resulting in weak host defences. Diabetes mellitus is known to be one of the major factors that promote the occurrence of fungal infections. Prolonged use of steroidal drugs or antibiotics may result in development of a fungal disease. Late identification of the diagnosis, narrow range of treatment plan guidelines with a poor prognosis of COVID associated mucormycosis has alarmed many healthcare professionals with a possibility of occurrence of an epidemic. Thus, an urgent initiative to bring this scenario to the concern of public health by conducting surveillance programs, prompt diagnostic and management measures is essential. Nationwide public awareness and education on COVID-19 and its related complications is necessary to promote the safety and welfare of the society at a global level. Aim: This study revolves to interpret the actual outline of this deadly infection by evaluating all the published case reviews to assess the various clinical forms of mucormycosis infection seen in COVID-19 affected patients (both active or revived) that involve its epidemiology, predisposing factor, clinical presentations, prognosis and treatment protocol with regard to COVID-19.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Research in Medical and Dental Science.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Research in Medical and Dental Science
  • SubjectDentistry & Oral Health
  • BylineArticles whose byline prints “Julie Ann Thomas”
  • BylineArticles whose byline prints “Vinoth S”
  • BylineArticles whose byline prints “Komal Muneshwar”
  • BylineArticles whose byline prints “Ashok Mehendale”